Related Experiment Video
Updated: May 17, 2026
06:05
The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
Algorithm for the evaluation of therapeutic failure reports--proposal and pilot analysis.
Claudia Patricia Vaca González1, Roxana Patricia De las salas Martínez, José Julián López Gutiérrez
1Pharmacy Department, Faculty of Sciences, Universidad Nacional de Colombia, Bogotá, Colombia. cpvacag@unal.edu.co
Pharmacoepidemiology and Drug Safety
|October 18, 2012
Summary
A new algorithm helps analyze suspected therapeutic failure (TF) reports in pharmacovigilance. It found inappropriate drug use, not manufacturing issues, as a key cause of alleged TF.
Area of Science:
- Pharmacovigilance
- Drug Safety
- Clinical Pharmacology
Background:
- Therapeutic failure (TF) reports in pharmacovigilance are complex and frequent.
- Accurate analysis of TF reports is crucial for drug safety monitoring.
Purpose of the Study:
- To develop and validate an algorithm for analyzing suspected therapeutic failure (TF) reports.
- To differentiate causes of alleged TF in pharmacovigilance data.
Main Methods:
- A Delphi consensus method involving 12 international experts.
- Development of a 10-question algorithm to analyze TF reports.
- Pilot analysis of 50 reports to assess interrater and intrarater reliability.
Main Results:
- Inappropriate drug use accounted for 28% of alleged TF.
- Manufacturing quality problems were attributed to only 8% of TF.
- 31% of reports lacked sufficient information for TF cause attribution.
- Moderate interrater reliability (kappa=0.55) and substantial to almost perfect intrarater reliability (0.732-0.908).
Conclusions:
- The proposed TF algorithm is a valid, reliable, and reproducible tool.
- The algorithm aids in clarifying complex TF reports.
- It highlights the importance of appropriate drug use in therapeutic outcomes.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...